Viewing Study NCT02089633


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-01-01 @ 5:21 AM
Study NCT ID: NCT02089633
Status: COMPLETED
Last Update Posted: 2017-07-28
First Post: 2014-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC
Sponsor: Bio-Cancer Treatment International Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module